Codexis, Inc. (CDXS)
NASDAQ · Manufacturing · Industrial organic chemicals
$1.32−$0.0500 (−3.65%) on the dayAs of the close; data may be delayed.
CDXS price, last 12 months
Key stats
- Previous close
- $1.37
- Open
- $1.38
- Day range
- $1.32 – $1.40
- 52-week range
- $0.9583 – $2.98
- Volume
- 464.7K
- Avg volume (20 days)
- 881.6K
- Market cap
- $144.5M
Performance
1W−2.9%
1M−20.0%
3M−44.8%
6M−20.5%
YTD−19.0%
1Y−46.8%
vs S&P 500, 1Y−63.6 pts
Technicals and fundamentals
About Codexis, Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
- Sector
- Manufacturing
- Industry
- Industrial organic chemicals
- Listed on
- NASDAQ
- Market cap
- $144.5M